Jarrod Longcor, Chief Business Officer at Cellectar Biosciences, Inc. (CLRB), bought 100 shares at $2.00 ($200) on 2019-02-28, disclosed to the SEC on 2019-03-01.
Open-market purchase of $200 CLRB by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CLRB | BUY | 2025-03-12 | $8K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $40K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $150K | — | Filing → |